Overview
- Provides an overview of purinergic signaling specifically in neurogenesis, brain physiology and brain diseases
- Covers the basic aspects and advancements in therapeutic applications of purinergic signaling and brain diseases
- Useful for academics at universities and research institutes professionals in the pharmaceutical industry and hospitals
Access this book
Tax calculation will be finalised at checkout
Other ways to access
Table of contents (15 chapters)
Keywords
- Purinergic Signaling
- purinergic receptors
- ectonucleotidases
- neurogenesis
- neurodegeneration
- Parkinson's disease
- Alzeheimer's disease
- Huntington's disease
- depressive disorders
- stem cells
- adenosine and aging
- brain physiology
- purinergic receptor agonist
- purinergic receptor antagonistic development
- neurodegenerative diseases
About this book
Editors and Affiliations
About the editors
Prof. Peter Illes has studied medicine in Budapest at the Semmelweis University of Medicine and has been Associate Professor in the Department of Pharmacology of the University of Freiburg and afterwards Full Professor and Director of the Department of Pharmacology of the University of Leipzig, Germany. Presently he holds a Chair at the Chengdu University of Traditional Chinese Medicine, China. He has obtained numerous awards and distinctions; he is also member of several professional organizations such as the Academia Europaea or the Czech Learned Society. He has been awarded by honorary Doctorates in Budapest, Hungary, and Chengdu, China and with a number of Honorary Professorships. He is neuroscientist with special emphasis on two types of ATP-sensitive receptors, belonging to the P2X3 and P2X7 class. These receptors regulate pain sensation and neurodegenerative processes, respectively. Dr. Illes has published more than 400 papers in peer-reviewed journals (H-factor of 60) and edited 3 books. He has been or is presently editorial board member of about 10 journals and is Editor-in-Chief of the Section Molecular Pharmacology of the International Journal of Molecular Sciences (IF=4.556).
Dr. Talita Glaser studied Biology at São Paulo University (Brazil) and performed her PhD thesis in Biochemistry and Neuroscience at the same university. She completed her training during PhD in Kyoto University followed by postdoctoral research training at the University of São Paulo and Harvard Medical School. She is actually a postdoctoral fellow at the laboratory of Prof. Henning Ulrich at the University of São Paulo. Even asa young investigator, her work on purinergic signalling and stem cells are well cited and known internationally. Dr. Glaser has published over 40 papers in peer-reviewed journals and (H-factor of 19, ca. 1284 citations) 6 book chapters. The results of her research were commented on by major Brazilian newspapers.
Bibliographic Information
Book Title: Purinergic Signaling in Neurodevelopment, Neuroinflammation and Neurodegeneration
Editors: Henning Ulrich, Peter Illes, Talita Glaser
DOI: https://doi.org/10.1007/978-3-031-26945-5
Publisher: Springer Cham
eBook Packages: Biomedical and Life Sciences, Biomedical and Life Sciences (R0)
Copyright Information: The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG 2023
Hardcover ISBN: 978-3-031-26944-8Published: 17 July 2023
Softcover ISBN: 978-3-031-26947-9Due: 17 August 2023
eBook ISBN: 978-3-031-26945-5Published: 16 July 2023
Edition Number: 1
Number of Pages: X, 376
Number of Illustrations: 31 b/w illustrations, 3 illustrations in colour
Topics: Neurosciences, Neurochemistry, Biomedicine, general, Regenerative Medicine/Tissue Engineering